Aejaz Nasir, MD

Personal Information

Publications

• Stromal-Based Signatures for the Classification of Gastric Cancer [M. Uhlik1, J. Liu1, B. Falcon1, S. Iyer2, J. Stewart1, H.Celikkaya2, M. O’Mahony2, C. Sevinsky3, C. Lowes3, L. Douglass4, C. Jeffries1, D. Bodenmiller1, S. Chintharlapalli1, A, Fischl1, D. Gerald2, Q. Xue2, J. Lee5, A. Santamaria-Pang3,Y. Al-Kofahi3,Y. Sui3, K. Desai3, T. Doman1, A. Aggarwal1, J. H. Carter4, B. Pytowski2, S. Jaminet6, F. Ginty3, A. Nasir1, J. Nagy6, H. Dvorak6, and L. Benjamin2]
• Heterogeneity of Vascular Endothelial Growth Factor Receptors 1, 2, 3 in Primary Human Colorectal Carcinoma [A. NASIR1, L. O’NEILL REISING1, D. NEDDERMAN1, A. FULFORD1, M. UHLIK2, L. BENJAMIN2, A. SCHADE1 and T. HOLZER1]
• Efficacy and safety of ramucirumabcontaining chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma [S. Mishima,1 A. Kawazoe,1 H. Matsumoto,1 Y. Kuboki,1 H. Bando,1 T. Kojima,1 T. Doi,1 A. Ohtsu,1 T. Yoshino,1 E. Nonte,2 S. Chintharlapalli,3 A. Nasir,2 T. Kuwata,4 K. Shitara1]
• Cancer Growth and Progression [Series Editors: A. Nasir, T.J. Yeatman]
• Cross-Platform Comparison of Computer-assisted Image Analysis Quantification of In Situ mRNA Hybridization in Investigative Pathology [T. Holzer, PhD, J. Hanson, MS, E. Wray, BS, J. Bailey, PhD, K. Kennedy, BS, P.. Finnegan, AS, A. Nasir, MD, MPhil, FCAP, and K. Credille, DVM, PhD, Dip. ACVP]
• EPB41L5 is Associated With the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors [J. SALLER1*, S. SEYDAFKAN1*, M. SHAHID1, M. GADARA1, M. CIVES2, S. ESCHRICH3, D. BOULWARE3, J. STROSBERG2, A. NASIR4, and D. COPPOLA1,5,6,7]
• Quantification of β-Catenin Signaling Components in Colon Cancer Cell Lines, Tissue Sections, and Microdissected Tumor Cells using Reaction Monitoring Mass Spectrometry [Y. Chen1, M. Gruidl1, E. Remily-Wood1, R. Liu1, S. Eschrich1, M. Lloyd1, A. Nasir1, M. Bui1, E. Huang2, D. Shibata1, T. Yeatman1, and J. Koomen1,*]
• A Novel Predictor of Liver Metastasis in Primary Pancreatic Endocrine Neoplasms [A. Nasir, MD, MPhil, FCAP*,†, J. Helm, MD, PhD‡, L. Turner, MD§, D. Chen, PhD‖, J. Strosberg, MD‡, N. Hafez, MD§, E. Henderson-Jackson, MD§, P. Hodul, MD¶, M. Bui, MD, PhD*, N. Nasir, MD#, A. Hakam, MD*, M. Malafa, MD¶, T. Yeatman, MD¶, D. Coppola, MD*, and L. Kvols, MD**]
• Tumor Cell Expression of Vascular Endothelial Growth Factor Receptor 2 Is an Adverse Prognostic Factor in Patients with Squamous Cell Carcinoma of the Lung [T. Holzer1, A. Fulford1, D. Nedderman1, T. Umberger1, R. Hozak2, A. Joshi2, S. Melemed1, L. Benjamin1, G. Plowman1, A. Schade1, B. Ackermann1, R. Konrad1, A. Nasir1* 1]

Honors & Awards

• Travel Grant North American Neuroendocrine Tumor Society (NANETS): Neuro-endocrine Tumor Symposium, Bermuda. Discovery and Validation of Progression-associated Genes in Primary Pancreatic Endocrine Tumors. 2008.
• Novartis Young Investigator Award: Young Investigator Meeting, Barcelona, Spain. Somatostatin receptor profiling of gastro-entero-hepatic neuroendocrine tumors: Immunohistochemical approach with potential clinical utility. 2005.
• ASCO Merit Award – American Society of Clinical Oncology Annual Meeting: Presented Abstract of distinction. Title: COX-2 and APC protein expression in colorectal cancer. 2003.
• General Iftekhar Malik Gold Medal: For best presentation at the Annual Meeting of the Pakistan Association of Pathologists, Quetta, Pakistan; Title: p53 in colorectal neoplasia. 1994.
• Pakistan Academy of Medical Sciences Bursary Award and Gold Medal: For post-residency research: Estrogen receptors in breast cancer. 1990.
• Bokhari Gold Medal: For best presentation at the Annual Meeting of the Pakistan Association of Pathologists, Peshawar, Pakistan. Title: Estrogen receptors and allied prognostic indicators in breast cancer. 1989.